Montelukast Improves Abdominal Aortic Aneurysms in Mice
Author Information
Author(s): Li Kexin, Li Meng, Wei Panpan, Tian Kangli, Liu Haole, Fu Weilai, Hou Haiwen, Chen Yajie, Xu Baohui, Li Yankui, Zhao Sihai
Primary Institution: Xi'an Jiaotong University Health Science Center
Hypothesis
Montelukast may improve nondissecting abdominal aortic aneurysms by inhibiting aortic inflammation.
Conclusion
Montelukast treatment improves experimental nondissected abdominal aortic aneurysms in mice partly by improving aortic inflammation.
Supporting Evidence
- Montelukast significantly decreased aortic expansion in a dose-dependent manner.
- Histopathological analysis showed improved aortic elastin degradation with montelukast treatment.
- Montelukast reduced local leucocyte infiltration in aortic aneurysmal lesions.
- Montelukast downregulated MMP2 and MMP9 expression in aneurysmal aortas.
- Montelukast treatment decreased mural neovessel density in the aorta.
Takeaway
Montelukast, a medicine usually for asthma, helps mice with a serious blood vessel problem by reducing inflammation.
Methodology
Nondissecting AAAs were induced in mice using porcine pancreatic elastase, followed by treatment with montelukast or vehicle for 14 days.
Limitations
Only the PPE-induced model was used; other models should be tested to confirm results.
Participant Demographics
Thirty male C57BL/6J mice, aged 9-12 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website